These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 8346828)

  • 1. Malignant hyperthermia: a review of published cases.
    Strazis KP; Fox AW
    Anesth Analg; 1993 Aug; 77(2):297-304. PubMed ID: 8346828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignant hyperthermia in Canada: characteristics of index anesthetics in 129 malignant hyperthermia susceptible probands.
    Riazi S; Larach MG; Hu C; Wijeysundera D; Massey C; Kraeva N
    Anesth Analg; 2014 Feb; 118(2):381-387. PubMed ID: 23842196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignant hyperthermia deaths related to inadequate temperature monitoring, 2007-2012: a report from the North American malignant hyperthermia registry of the malignant hyperthermia association of the United States.
    Larach MG; Brandom BW; Allen GC; Gronert GA; Lehman EB
    Anesth Analg; 2014 Dec; 119(6):1359-66. PubMed ID: 25268394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignant hyperthermia when dantrolene is not readily available.
    Gong X
    BMC Anesthesiol; 2021 Apr; 21(1):119. PubMed ID: 33863282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical presentation, treatment, and complications of malignant hyperthermia in North America from 1987 to 2006.
    Larach MG; Gronert GA; Allen GC; Brandom BW; Lehman EB
    Anesth Analg; 2010 Feb; 110(2):498-507. PubMed ID: 20081135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignant hyperthermia in maxillofacial surgery: Literature review supported by case presentation.
    Aires CCG; de Souza RRL; Amorim JA; Santos FG; Diniz DA; Carneiro SCAS; Vasconcellos RJH
    Spec Care Dentist; 2023 Jan; 43(1):99-108. PubMed ID: 35667046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac arrests and deaths associated with malignant hyperthermia in north america from 1987 to 2006: a report from the north american malignant hyperthermia registry of the malignant hyperthermia association of the United States.
    Larach MG; Brandom BW; Allen GC; Gronert GA; Lehman EB
    Anesthesiology; 2008 Apr; 108(4):603-11. PubMed ID: 18362591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pediatric malignant hyperthermia: risk factors, morbidity, and mortality identified from the Nationwide Inpatient Sample and Kids' Inpatient Database.
    Salazar JH; Yang J; Shen L; Abdullah F; Kim TW
    Paediatr Anaesth; 2014 Dec; 24(12):1212-6. PubMed ID: 24974921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of malignant hyperthermia reactions in 2,214 patients undergoing muscle biopsy.
    Carr AS; Lerman J; Cunliffe M; McLeod ME; Britt BA
    Can J Anaesth; 1995 Apr; 42(4):281-6. PubMed ID: 7788824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Registration of peranesthetic cases of malignant hyperthermia in France. An update].
    Jacquot C; Stieglitz P; Kozak-Reiss G; Krivosic-Horber R; Laxenaire MC; Lienhart A; Nivoche Y
    Ann Fr Anesth Reanim; 1988; 7(6):524-34. PubMed ID: 3223647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimate of the relative risk of succinylcholine for triggering malignant hyperthermia.
    Dexter F; Epstein RH; Wachtel RE; Rosenberg H
    Anesth Analg; 2013 Jan; 116(1):118-22. PubMed ID: 23223104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the clinical variables associated with recrudescence after malignant hyperthermia reactions.
    Burkman JM; Posner KL; Domino KB
    Anesthesiology; 2007 May; 106(5):901-6; quiz 1077-8. PubMed ID: 17457120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complications associated with the administration of dantrolene 1987 to 2006: a report from the North American Malignant Hyperthermia Registry of the Malignant Hyperthermia Association of the United States.
    Brandom BW; Larach MG; Chen MS; Young MC
    Anesth Analg; 2011 May; 112(5):1115-23. PubMed ID: 21372281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dantrolene in human malignant hyperthermia.
    Kolb ME; Horne ML; Martz R
    Anesthesiology; 1982 Apr; 56(4):254-62. PubMed ID: 7039419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperthermia in the pediatric intensive care unit--is it malignant hyperthermia?
    Schleelein LE; Litman RS
    Paediatr Anaesth; 2009 Nov; 19(11):1113-8. PubMed ID: 19694974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignant hyperthermia in children: an analysis of the North American malignant hyperthermia registry.
    Nelson P; Litman RS
    Anesth Analg; 2014 Feb; 118(2):369-374. PubMed ID: 24299931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The severity of sevoflurane-induced malignant hyperthermia.
    Migita T; Mukaida K; Kobayashi M; Hamada H; Kawamoto M
    Acta Anaesthesiol Scand; 2012 Mar; 56(3):351-6. PubMed ID: 22092278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of malignant hyperthermia in Denmark.
    Ording H
    Anesth Analg; 1985 Jul; 64(7):700-4. PubMed ID: 4014731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anaesthesia in malignant hyperthermia-susceptible patients without dantrolene prophylaxis: a report of 30 cases.
    Hackl W; Mauritz W; Winkler M; Sporn P; Steinbereithner K
    Acta Anaesthesiol Scand; 1990 Oct; 34(7):534-7. PubMed ID: 2244439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Two pediatric cases of malignant hyperthermia caused by sevoflurane].
    Kinouchi K; Okawa M; Fukumitsu K; Tachibana K; Kitamura S; Taniguchi A
    Masui; 2001 Nov; 50(11):1232-5. PubMed ID: 11758332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.